CTRI/2009/091/000129已完成3 期
A Prospective, Open label, Randomized, Comparative, Multicentric trial to evaluate the Efficacy and Safety of Desvenlafaxine succinate ER tablet in the Management of Major Depressive Disorder
Emcure Pharmaceuticals Limited Pune0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Subject of either sex and age between 18-65 years
- •2.Subject with Major Depressive Disorder of at least 4 weeks' duration
- •3.Subject with Hamilton rating score for depression more then 17
排除标准
- •1.Patient with features of psychosis
- •2.Subjects with bipolar disorder
- •3.Concomitant use of other antidepressants
- •4.Endocrine disease other than Type 2 diabetes
- •5.Hypersensitivity to Venlafaxine or Desvenlafaxine
- •6.History of arrhythmias
- •7.History of congestive heart failure
- •8.History of coronary artery disease
- •9.History of stroke
- •10.Severe hypertension
- •11.Liver impairment
- •12.Narrow angle glaucoma
- •13.Untreated hypothyroidism or hyperthyroidism
- •14.Pulmonary hypertension
- •15.Renal impairment
- •16.History of seizures
- •17.Alcohol abuse
- •18.Psychoactive substance abuse
- •19.Recent tobacco cessation
- •20.Lactating or pregnant women
- •21.Any condition that, in the opinion of the investigator, does not justify the subjects? inclusion in the study
研究者
相似试验
尚未招募
不适用
Efficacy and safety of Levonadifloxacin versus Teicoplanin-Azithromycin combination in hospitalized patients with Community Acquired Bacterial Pneumonia (CABP)CTRI/2022/05/042613Dr Anand Nikalje
尚未招募
4 期
To assess the efficacy and safety of a probiotic product (Streptococcus salivarius K12) in children with recurrent upper respiratory tract infection.CTRI/2024/01/061611Dr Reddy’s Laboratories Ltd
尚未招募
不适用
EEfficacy and safety of Levonadifloxacin with Teicoplanin-Aztreonam combination in patients with Acute Bacterial Skin and Skin Structure Infection (ABSSSI) including diabetic foot infectioCTRI/2022/06/043031Dr Anand Nikalje
暂停
3 期
A study of Favipiravir in patients with mild to moderate coronavirus disease (COVID-19)CTRI/2020/06/025799Cipla Ltd
已完成
3 期
A clinical trial to study the Effect and Safety of the Ropivacaine Readyfusor 2mg/ml as a continuous surgical site infusion device with device available in market for the Treatment of Post-Surgical Pain in lower abdominal surgeries.CTRI/2019/09/021200Cipla Ltd155